Abstract: The present invention lies in the field of the manufacture of phenol from cumene. The subject of the invention is a process for the continuous preparation of cumene hydroperoxide by oxidation, in the liquid phase, of cumene in the presence of oxygen. The process according to the invention is carried out in the presence of at least one agent chosen from the hydroxide or the carbonate of an alkali metal and/or alkaline-earth metal; the said agent being used in an amount of between 2 and 10 ppb (expressed as sodium hydroxide) with respect to the amount of cumene introduced. The invention likewise relates to the use of the hydroperoxide thus obtained for preparing phenol.

Abstract: The invention relates to the use of a compound selected from:?.alpha.-(tert-butylaminomethyl)-3,4-dichlorobenzyl!thioacetamide and its laevorotatory isomer,?.alpha.-(tert-amylaminomethyl)-3,4-dichlorobenzyl!thioacetamide and its isomers,?.alpha.-(1-adamantylaminomethyl)3,4-dichlorobenzyl!thioacetamide and its isomers,as well as the addition salts of these compounds with pharmaceutically acceptable acids, for inhibiting dopamine reuptake.

Abstract: The present invention relates to compounds of formula (I) wherein R.sub.1 is selected from H and 3-chloro; R.sub.2 is selected from a phenyl group and a pyridyl group; R.sub.3 and R.sub.4 are selected independently of each other from H and methyl; R.sub.5 and R.sub.6 are selected independently of each other from H and a pyridyl-methyl group or both represent an ethyl group; n=0 or 1; R.sub.1, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are not simultaneously H when R.sub.2 is phenyl. The salts of the compounds have a pyridyl group with pharmaceutical acceptable acids are also disclosed.

Abstract: The invention relates to a process which comprises the crystallization of a calcium salt of chiral (R or S) lactic acid esterified with a racemic dihydropyridine.

Abstract: The present invention relates to the utilization of modafinil for the treatment of ventilation disorders of central origin such as sleep apnea.

Abstract: The invention relates to a compound of formula: ##STR1## and its addition salts with pharmaceutically acceptable acids. These compounds are useful in therapy as sedatives.

Abstract: The present invention relates to the use of modafinil for the manufacture of a medicinal product for the treatment of urinary and fecal incontinence and urethrovesical and anal sphincteral disorders.

Abstract: The device comprises at least one element for immobilizing certain molecules contained in the medium to be tested. According to the invention, the immobilizing element is in the form of a hydrophilic material fixed on the surface of a plane hydrophobic material, such as for example viscose fibers (2) implanted by flocking into a sheet (3) of polyvinyl chloride. The device (4) further comprises:(a) a bottom plate (5) supporting the plane hydrophobic material,(b) at least one cavity (6) for the liquid medium to be tested, said cavity having an outlet orifice (9) situated above the plane hydrophobic material, and(c) scraping means (8) acting on the hydrophilic material (1) and capable of moving the liquid contained therein over the surface of the plane hydrophobic material (3).